IMMUNO TECHNOLOGIES INC
Memphis, TN · Medtech · Private
Multiplexed EIA diagnostic assay detecting antibody isotypes and IgG subclasses to Borrelia burgdorferi antigens for objective Lyme disease stage discrimination
immunotechnologies.com →- Grants
- $6.8M
- 10 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201420162018202020222024
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase II · Lab on a chip point of care assay for the rapid serodiagnosis of Lyme disease | $1,000,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Lab on a chip point of care assay for the rapid serodiagnosis of Lyme disease | $1,000,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Point of care assay for serodiagnosis of Leptospirosis | $300,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Point of care assay for serodiagnosis of Leptospirosis | $300,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Antibody isotyping for discrimination of disease stage and diagnosis of early Lyme disease. | $298,123 | |
| Federal grant | Department of Health and Human Services · Phase I · Antibody isotyping for discrimination of disease stage and diagnosis of early Lyme disease. | $593,637 | |
| Federal grant | Department of Health and Human Services · Phase I · Antibody isotyping for discrimination of disease stage and diagnosis of early Lyme disease. | $295,514 | |
| Federal grant | Department of Health and Human Services · Phase II · Intranasal Vaccine Against Lyme Disease | $988,528 | |
| Federal grant | Department of Health and Human Services · Phase II · Intranasal Vaccine Against Lyme Disease | $1,000,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Intranasal Vaccine Against Lyme Disease | $999,881 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1177 | MARVEL MEDTECH, LLC | — | — |
| 1178 | EvoEndo, Inc. | — | $4.7M |
| 1179 | ANALYTICAL DIAGNOSTIC SOLUTIONS INC | — | — |
| 1180 | IMMUNO TECHNOLOGIES INC | — | — |
| 1181 | PERFUSIO CORP. | — | $11M |
| 1182 | INIA BIOSCIENCES, INC. | — | $200K |
| 1183 | INTRINSIC LIFESCIENCES, LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.